Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Nabriva Therapeutics plc (NBRV)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
2 Aug 2022
BURGESS DANIEL D
Director
Nabriva Therapeutics plc
(NBRV)
10,384
-52%
11,341
$0.19
$2,155.92
SELL
2 Aug 2022
Broom Colin MD
Director
Nabriva Therapeutics plc
(NBRV)
36,523
-12%
5,339
$0.19
$1,015.48
SELL
2 Aug 2022
Webster Stephen W
Director
Nabriva Therapeutics plc
(NBRV)
11,447
-40%
7,826
$0.19
$1,486.94
SELL
2 Aug 2022
CORRIGAN MARK
Director
Nabriva Therapeutics plc
(NBRV)
7,203
-58%
10,297
$0.19
$1,956.43
SELL
1 Aug 2022
Bourdow Carrie L.
Director
Nabriva Therapeutics plc
(NBRV)
9,933
-46%
8,540
$0.17
$1,486.81
BUY
28 Dec 2021
Schroeder Theodore R
Chief Executive Officer, Director, Officer
Nabriva Therapeutics plc
(NBRV)
325,879
+44%
100,000
$0.57
$57,320.00
BUY
27 Dec 2021
Naftzger J. Christopher
General Counsel and Corp Sec, Officer
Nabriva Therapeutics plc
(NBRV)
7,000
+100%
7,000
$0.59
$4,130.00
BUY
14 Sep 2021
Schroeder Theodore R
Chief Executive Officer, Director, Officer
Nabriva Therapeutics plc
(NBRV)
226,875
+28%
50,000
$1.13
$56,500.00
SELL
2 Aug 2021
Broom Colin MD
Director
Nabriva Therapeutics plc
(NBRV)
41,862
-1%
531
$1.20
$637.20
SELL
2 Aug 2021
BURGESS DANIEL D
Director
Nabriva Therapeutics plc
(NBRV)
21,725
-4%
1,125
$1.20
$1,350.00
SELL
2 Aug 2021
Rowland Charles A Jr
Director
Nabriva Therapeutics plc
(NBRV)
23,773
-3%
777
$1.20
$932.40
SELL
2 Aug 2021
Webster Stephen W
Director
Nabriva Therapeutics plc
(NBRV)
19,273
-3%
777
$1.20
$932.40
SELL
2 Aug 2021
Bourdow Carrie L.
Director
Nabriva Therapeutics plc
(NBRV)
18,473
-4%
777
$1.20
$932.40
SELL
19 Aug 2020
Broom Colin MD
Director
Nabriva Therapeutics plc
(NBRV)
248,936
-0%
1,106.4
$6.48
$7,165.05
SELL
1 Aug 2020
Rowland Charles A Jr
Director
Nabriva Therapeutics plc
(NBRV)
15,277
-5%
849.6
$1.75
$1,486.80
BUY
30 Aug 2019
Broom Colin MD
Director
Nabriva Therapeutics plc
(NBRV)
208,750
+0%
1,017.7
$20.31
$20,668.47
BUY
27 Aug 2019
Schroeder Theodore R
Chief Executive Officer, Director, Officer
Nabriva Therapeutics plc
(NBRV)
117,489
+4%
5,000
$17.90
$89,500.00
BUY
22 Aug 2019
Lavino Francesco Maria
Chief Commercial Officer, Officer
Nabriva Therapeutics plc
(NBRV)
15,972
+3%
480
$20.37
$9,780.00
BUY
24 Dec 2018
Rowland Charles A Jr
Director
Nabriva Therapeutics plc
(NBRV)
53,000
+11%
5,300
$13.10
$69,430.00
BUY
31 Jul 2018
BURGESS DANIEL D
Director
Nabriva Therapeutics plc
(NBRV)
36,000
+11%
3,600
$27.50
$99,000.00
BUY
31 Jul 2018
Talbot George Harrison
Director
Nabriva Therapeutics plc
(NBRV)
47,640
+3%
1,450
$27.50
$39,875.00
BUY
23 Jun 2018
Gelone Steven P.
Chief Scientific Officer, Officer
Nabriva Therapeutics plc
(NBRV)
22,740
+4%
1,000
$38.20
$38,200.00
BUY
22 Jun 2018
Broom Colin MD
CEO & Director, Director, Officer
Nabriva Therapeutics plc
(NBRV)
102,151
+0%
500
$37.20
$18,600.00
BUY
22 Jun 2018
Schranz Jennifer
Chief Medical Officer, Officer
Nabriva Therapeutics plc
(NBRV)
5,500
+11%
550
$37.30
$20,515.00
BUY
23 May 2018
Lavino Francesco Maria
Chief Commercial Officer, Officer
Nabriva Therapeutics plc
(NBRV)
3,719
+6%
216
$46.00
$9,936.00
BUY
23 May 2018
Broom Colin MD
CEO & Director, Director, Officer
Nabriva Therapeutics plc
(NBRV)
97,151
+1%
1,000
$46.00
$46,000.00
BUY
23 May 2018
Sender Gary
Chief Financial Officer, Officer
Nabriva Therapeutics plc
(NBRV)
6,200
+3%
200
$45.70
$9,140.00
BUY
23 May 2018
Webster Stephen W
Director
Nabriva Therapeutics plc
(NBRV)
8,000
+11%
800
$45.90
$36,720.00
BUY
23 May 2018
Crotty Robert
General Counsel & Secretary, Officer
Nabriva Therapeutics plc
(NBRV)
10,000
+11%
1,000
$44.80
$44,800.00
BUY
29 Nov 2017
Lavino Francesco Maria
Chief Commercial Officer, Officer
Nabriva Therapeutics plc
(NBRV)
1,569
+11%
156.9
$62.90
$9,869.01
BUY
22 Sep 2017
Broom Colin MD
Chief Executive Officer, Director, Officer
Nabriva Therapeutics plc
(NBRV)
87,151
+0%
258.8
$83.50
$21,609.80
BUY
22 Sep 2017
Sender Gary
Chief Financial Officer, Officer
Nabriva Therapeutics plc
(NBRV)
4,200
+5%
200
$82.10
$16,420.00
BUY
18 Sep 2017
Vivo Capital VIII, LLC
10% Owner
Nabriva Therapeutics plc
(NBRV)
3,579,861
+0%
5,263.1
$94.60
$497,889.25
SELL
12 Sep 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics plc
(NBRV)
2,334,128
-0%
3,660.8
$85.61
$313,415.00
SELL
31 Aug 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics plc
(NBRV)
2,370,735
-0%
63.9
$95.00
$6,070.50
SELL
7 Aug 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics plc
(NBRV)
2,371,374
-0%
1,980.3
$105.00
$207,932.11
SELL
28 Jul 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics plc
(NBRV)
2,391,177
-0%
658.5
$105.08
$69,195.18
SELL
24 Jul 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics plc
(NBRV)
2,397,762
-0%
16
$105.00
$1,680.00
SELL
19 Jul 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics plc
(NBRV)
2,397,922
-0%
4,423.1
$105.00
$464,425.50
SELL
30 Jun 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
2,571,877
-0%
1,312.7
$109.45
$143,670.36
SELL
27 Jun 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
2,585,004
-0%
855.8
$109.61
$93,804.00
SELL
15 Jun 2017
Talbot George Harrison
Director
Nabriva Therapeutics AG
(NBRV)
3,179
-0%
17
$931.76
$15,840.00
SELL
1 Jun 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
2,593,562
-0%
40
$112.70
$4,508.00
SELL
30 May 2017
Talbot George Harrison
Director
Nabriva Therapeutics AG
(NBRV)
3,449
-0%
21
$1,012.62
$21,265.00
SELL
23 May 2017
Talbot George Harrison
Director
Nabriva Therapeutics AG
(NBRV)
3,649
-0%
32.5
$1,005.65
$32,683.50
SELL
26 Apr 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
2,593,962
-0%
1,593.9
$110.24
$175,711.80
SELL
21 Apr 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
2,609,901
-0%
262.2
$110.36
$28,937.44
SELL
18 Apr 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
2,612,523
-0%
2,393.2
$111.10
$265,889.34
SELL
11 Apr 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
2,636,455
-0%
3,283.1
$112.37
$368,919.38
SELL
6 Apr 2017
HBM Healthcare Investments (Cayman) Ltd.
10% Owner
Nabriva Therapeutics AG
(NBRV)
185,394
-4%
9,059.4
$109.56
$992,541.90
SELL
16 Feb 2017
Talbot George Harrison
Director
Nabriva Therapeutics AG
(NBRV)
3,984
-0%
20
$1,024.42
$20,488.40
Home